Semra Salimoğlu
Semra Salimoğlu has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Cengiz Aydin
University of Health Sciences Tepecik Training and Research Hospital, Department of General Surgery, İzmir, TURKEY
3 shared publications - Semra Demirli Atici
Department of General Surgery Acibadem Kent Hospital İzmir Turkey
3 shared publications - Cem Karaali
Department of General Surgery University of Health Sciences Izmir
2 shared publications - Gulen Gul
University of Health Sciences Tepecik Training and Research Hospital, Department of Pathology
2 shared publications - Buğra SAĞLAM
Department of General Surgery, University of Health Sciences Türkiye, İzmir Tepecik Education and Research Hospital, İzmir, Türkiye
1 shared publication - Canan Kelten Talu
Department of Pathology, University of Health Sciences, Tepecik Training and Research Hospital, İzmir, Türkiye
1 shared publication
Latest Publications
- 1 January 2024
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 20 (1) , 19-24
The Clinical and Pathological Characteristics That Differentiate Cases With “Low Estrogen Receptor Expression” From Triple-Negative Breast Cancer
Estrogen receptor (ER) expression is an immunohistochemical marker that is examined in all invasive breast cancers and has prognostic and predictive value. ER-positive breast cancers refer to those that show positivity for ER at 1% cellular expression or higher. The American Society of Clinical Oncology/College of American Pathologists guidelines suggest using the term “low ER-positive breast cancer” for tumors with ER expression between 1% and 10%. Low ER-positive breast cancers exhibit similarities, in terms of disease-free survival and overall survival rates, to triple-negative breast cancers (TNBCs) rather than ER-positive breast cancers. In this study, our aim was to compare the clinicopathological characteristics of low ER-positive breast cancer cases diagnosed and followed in our clinic with TNBCs. A total of 26 cases of low ER-positive breast cancer diagnosed at University of Health Sciences Turkey, İzmir Tepecik Training and Research Hospital between 2010 and 2016 were retrieved from hospital records. The relevant histopathology slides and blocks were retrieved and re-evaluated retrospectively through microscopic examination. Thirteen cases that met the criteria were included in the study. Additionally, a consecutive series of 13 TNBC cases that did not receive neoadjuvant treatment within the same time period were identified. In the low ER-positive group, the presence of tumor necrosis, as well as histological grade, nuclear grade and Ki-67 proliferation index were significantly lower compared to the TNBC group. Ductal carcinoma in situ (DCIS) was significantly more common in the low ER-positive group compared to the TNBC group. There were no significant differences between the two groups in terms of tumor size, histological tumor type, axillary lymph node involvement, tumor margins, peritumoral and intratumoral inflammation, local recurrence, distant metastasis, survival, and other characteristics. Although our study consisted of a small number of cases, some features showed significant differences between low ER-positive breast cancers and TNBCs. Histological and nuclear grades, as well as the presence of a DCIS component, were associated with low ER-positive breast cancer. In contrast, the presence of tumor necrosis, as well as Grade 3 features and a high Ki-67 proliferation index indicated TNBC.
- 1 January 2024
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 20 (1) , 19-24
The Clinical and Pathological Characteristics That Differentiate Cases With “Low Estrogen Receptor Expression” From Triple-Negative Breast Cancer
Estrogen receptor (ER) expression is an immunohistochemical marker that is examined in all invasive breast cancers and has prognostic and predictive value. ER-positive breast cancers refer to those that show positivity for ER at 1% cellular expression or higher. The American Society of Clinical Oncology/College of American Pathologists guidelines suggest using the term “low ER-positive breast cancer” for tumors with ER expression between 1% and 10%. Low ER-positive breast cancers exhibit similarities, in terms of disease-free survival and overall survival rates, to triple-negative breast cancers (TNBCs) rather than ER-positive breast cancers. In this study, our aim was to compare the clinicopathological characteristics of low ER-positive breast cancer cases diagnosed and followed in our clinic with TNBCs. A total of 26 cases of low ER-positive breast cancer diagnosed at University of Health Sciences Turkey, İzmir Tepecik Training and Research Hospital between 2010 and 2016 were retrieved from hospital records. The relevant histopathology slides and blocks were retrieved and re-evaluated retrospectively through microscopic examination. Thirteen cases that met the criteria were included in the study. Additionally, a consecutive series of 13 TNBC cases that did not receive neoadjuvant treatment within the same time period were identified. In the low ER-positive group, the presence of tumor necrosis, as well as histological grade, nuclear grade and Ki-67 proliferation index were significantly lower compared to the TNBC group. Ductal carcinoma in situ (DCIS) was significantly more common in the low ER-positive group compared to the TNBC group. There were no significant differences between the two groups in terms of tumor size, histological tumor type, axillary lymph node involvement, tumor margins, peritumoral and intratumoral inflammation, local recurrence, distant metastasis, survival, and other characteristics. Although our study consisted of a small number of cases, some features showed significant differences between low ER-positive breast cancers and TNBCs. Histological and nuclear grades, as well as the presence of a DCIS component, were associated with low ER-positive breast cancer. In contrast, the presence of tumor necrosis, as well as Grade 3 features and a high Ki-67 proliferation index indicated TNBC.
- Open Access
- 3 January 2020
- Published by The European Research Journal in The European Research Journal
- Vol. 6 (1) , 73-76
Chondroid metaplasia: a rare subtype of metaplastic breast carcinoma
Metaplastic breast carcinoma (MBC) is a subtype of breast malignant lesions which is very rare seen. Clinically, MBC is more aggressive and has worse prognosis than other subtypes of breast cancers. A 61-year-old female patient who had a rapidly enlarging and palpabl mass on the left breast applied. Core biopsy was performed and pathology was reported as invasive ductal carcinoma. The patient who had been diagnosed with breast cancer was operated and postoperative course was unremarkable. She was discharged postoperative third day with no complication. Postoperative specimen pathology was reported as a rare type of breast metaplastic carcinoma which was chondroid metaplasia. Here we aimed to report, a case of chondroid metaplasia which is a rare type of metaplastic breast carcinoma with the literature.
- 3 January 2020
- Published by The European Research Journal in The European Research Journal
- Vol. 6 (1) , 73-76
Open AccessChondroid metaplasia: a rare subtype of metaplastic breast carcinoma
Metaplastic breast carcinoma (MBC) is a subtype of breast malignant lesions which is very rare seen. Clinically, MBC is more aggressive and has worse prognosis than other subtypes of breast cancers. A 61-year-old female patient who had a rapidly enlarging and palpabl mass on the left breast applied. Core biopsy was performed and pathology was reported as invasive ductal carcinoma. The patient who had been diagnosed with breast cancer was operated and postoperative course was unremarkable. She was discharged postoperative third day with no complication. Postoperative specimen pathology was reported as a rare type of breast metaplastic carcinoma which was chondroid metaplasia. Here we aimed to report, a case of chondroid metaplasia which is a rare type of metaplastic breast carcinoma with the literature.
- Open Access
- 20 December 2019
- Published by Ege Tip Bilimleri Dergisi in Ege Tıp Bilimleri Dergisi
- Vol. 2 (3) , 134-136
Idiopathic Granulomatous Mastitis, A Rare Cause of Male Breast Mass
Granulomatous mastitis (GM) is a chronic benign inflammatory disorder of the breast which is extremely rarely seen in male patients, and the prognosis is not well known mainly due to limited cases reported in the literature. A 76- year -old male patient presented with nipple discharge and a palpable painless lump in his right breast for one month. Breast ultrasonography showed a 19x11 mm size of a mass which has components solid hypoechoic, irregular shape. A presumptive diagnosis of breast carcinoma due to imaging methods and the core biopsy which was unclear, simple mastectomy and sentinel lymph node biopsy was performed. The patient was discharged uneventfully on the second postoperative day. The histopathological findings supported the diagnosis of idiopathic granulomatosis mastitis. Male granulomatous mastitis which reported in the literature has unclear pathogenesis. It will be necessary to accumulate more case reports about GM in order to define risk factors and optimizing the treatment.
- 20 December 2019
- Published by Ege Tip Bilimleri Dergisi in Ege Tıp Bilimleri Dergisi
- Vol. 2 (3) , 134-136
Open AccessIdiopathic Granulomatous Mastitis, A Rare Cause of Male Breast Mass
Granulomatous mastitis (GM) is a chronic benign inflammatory disorder of the breast which is extremely rarely seen in male patients, and the prognosis is not well known mainly due to limited cases reported in the literature. A 76- year -old male patient presented with nipple discharge and a palpable painless lump in his right breast for one month. Breast ultrasonography showed a 19x11 mm size of a mass which has components solid hypoechoic, irregular shape. A presumptive diagnosis of breast carcinoma due to imaging methods and the core biopsy which was unclear, simple mastectomy and sentinel lymph node biopsy was performed. The patient was discharged uneventfully on the second postoperative day. The histopathological findings supported the diagnosis of idiopathic granulomatosis mastitis. Male granulomatous mastitis which reported in the literature has unclear pathogenesis. It will be necessary to accumulate more case reports about GM in order to define risk factors and optimizing the treatment.
- Open Access
- 30 August 2019
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 21 (2) , 142-144
Memede Kitlenin Nadir Bir Nedeni: Granüler Hücreli Tümör
Granular cell tumor is a rare type of soft tissue tumor originated from Schwann cells and often affecting head and neck region. Granular cell tumor, which may have many different organ involvements in the body, can rarely observed in breast tissue. A 57-year-old postmenopausal woman underwent excisional biopsy in another health facility due to a palpable rapidly growing painless mass on her left breast. Re-excision with wide surgical margins was performed to the patient whose biopsy was reported as granular cell tumor of breast with positive surgical margin. Postoperative follow-up was uneventful, and the patient was discharged without complication. Wide local excision should be performed to prevent local recurrence in the surgical treatment of granular cell breast tumor, which is similar to breast carcinoma in both radiological and clinic appearance. In this case report, we aimed to present diagnosis and treatment of granular cell tumor with current literature knowledge.
- 30 August 2019
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 21 (2) , 142-144
Open AccessMemede Kitlenin Nadir Bir Nedeni: Granüler Hücreli Tümör
Granular cell tumor is a rare type of soft tissue tumor originated from Schwann cells and often affecting head and neck region. Granular cell tumor, which may have many different organ involvements in the body, can rarely observed in breast tissue. A 57-year-old postmenopausal woman underwent excisional biopsy in another health facility due to a palpable rapidly growing painless mass on her left breast. Re-excision with wide surgical margins was performed to the patient whose biopsy was reported as granular cell tumor of breast with positive surgical margin. Postoperative follow-up was uneventful, and the patient was discharged without complication. Wide local excision should be performed to prevent local recurrence in the surgical treatment of granular cell breast tumor, which is similar to breast carcinoma in both radiological and clinic appearance. In this case report, we aimed to present diagnosis and treatment of granular cell tumor with current literature knowledge.
- 4 April 2019
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 15 (2) , 125-129
Loss of Nuclear ARID-1A Expressions Is Associated with Hormone Receptor Status in Breast Cancers
Breast cancer is the most common cancer among women worldwide. Adenine thymine-rich interactive domain 1A (ARIDIA) is a tumor suppressor gene involved in chromatin remodeling and it encodes the ARIDIA protein. Recent studies have shown the loss of ARIDIA protein expression in different carcinomas may have a prognostic significance. In the present study, we aimed to evaluate the interactions between ARIDIA loss and molecular subtypes of breast carcinomas. ARIDIA expressions were studied in 292 formalin- fixed, paraffin- embedded breast carcinoma specimens and its association with different pathological and clinical parameters was evaluated. Loss of ARIDIA expression was detected in 123 cases. There was no statistically significant association between ARID-1A expression and molecular subtype of breast carcinomas (p=0.110) or HER2 amplification (p=0.909). Contrarily, there was a significant association between ARIDIA expression and presence of estrogen (p=0.047) or progesterone receptors (p=0.023). Besides a statistically significant relationship was found between loss of ARID1A, and the presence of both in situ component (p=0.016) and lymph node metastasis (p=0.001). In this study, we have demonstrated that loss of ARID1A expression positively correlates with hormone receptor status as well as tumor aggressiveness.
- 4 April 2019
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 15 (2) , 125-129
Loss of Nuclear ARID-1A Expressions Is Associated with Hormone Receptor Status in Breast Cancers
Breast cancer is the most common cancer among women worldwide. Adenine thymine-rich interactive domain 1A (ARIDIA) is a tumor suppressor gene involved in chromatin remodeling and it encodes the ARIDIA protein. Recent studies have shown the loss of ARIDIA protein expression in different carcinomas may have a prognostic significance. In the present study, we aimed to evaluate the interactions between ARIDIA loss and molecular subtypes of breast carcinomas. ARIDIA expressions were studied in 292 formalin- fixed, paraffin- embedded breast carcinoma specimens and its association with different pathological and clinical parameters was evaluated. Loss of ARIDIA expression was detected in 123 cases. There was no statistically significant association between ARID-1A expression and molecular subtype of breast carcinomas (p=0.110) or HER2 amplification (p=0.909). Contrarily, there was a significant association between ARIDIA expression and presence of estrogen (p=0.047) or progesterone receptors (p=0.023). Besides a statistically significant relationship was found between loss of ARID1A, and the presence of both in situ component (p=0.016) and lymph node metastasis (p=0.001). In this study, we have demonstrated that loss of ARID1A expression positively correlates with hormone receptor status as well as tumor aggressiveness.
- Open Access
- 1 January 2011
- Published by Galenos Yayinevi in The Anatolian Journal of General Medical Research
- Vol. 21 (2) , 95-98
Late Complication In Patient With Traumatic Diaphragmatic Defect: Internal Hernia
- 1 January 2011
- Published by Galenos Yayinevi in The Anatolian Journal of General Medical Research
- Vol. 21 (2) , 95-98
Open AccessLate Complication In Patient With Traumatic Diaphragmatic Defect: Internal Hernia